IPO registrations (S-1, F-1) · Registrants
Clene Inc.
- SEC CIK
- 1822791 · filings on EDGAR ↗
- Former names
- Chelsea Worldwide Inc. (2020–2020)
- Registration
- Form S-1, first filed 2021-02-17, last 2021-07-22; 2 initial registrations, 1 amendment
- Outcome
- Declared effective 2021-04-19
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, Salt Lake City, UT 84121
- EIN
- 85-2828339
- Ticker
- CLNN (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Clene Inc. on the corporate pages
On this site
- Form D issuer: Clene Inc. EXACT (CIK (EXACT))
- SEC filer: Clene Inc. EXACT (CIK (EXACT))
- Person page: David J Matlin Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-02-17 | S-1 | S-1 (registration) | Clene Inc. | 0001213900-21-009741 ↗ |
| 2021-03-29 | S-1/A | S-1/A (amendment) | Clene Inc. | 0001213900-21-018094 ↗ |
| 2021-04-19 | EFFECT | EFFECT (declared effective) | Clene Inc. | 9999999995-21-001483 ↗ |
| 2021-07-22 | S-1 | S-1 (registration) | Clene Inc. | 0001213900-21-038144 ↗ |
| 2021-08-02 | EFFECT | EFFECT (declared effective) | Clene Inc. | 9999999995-21-003029 ↗ |
| 2022-01-13 | EFFECT | EFFECT (declared effective) | Clene Inc. | 9999999995-22-000124 ↗ |
| 2022-04-26 | EFFECT | EFFECT (declared effective) | Clene Inc. | 9999999995-22-001102 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-22 | S-1 | registration statement | $8.51 | - | - | Nasdaq CLNN | 0 | primary document; price sentence | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Etherington Robert Dee | Director,Officer | Chief Executive Officer; President & CEO | 22 | 2021–2026 | |
| Gay Jonathon | Director | 29 | 2021–2026 | ||
| Glanzman Robert | Officer | Chief Medical Officer | 7 | 2021–2022 | |
| Jacobovitz Shalom | Director | 28 | 2021–2026 | ||
| Jeong Tae Heum | Officer | Chief Finance Officer | 4 | 2021 | |
| MATLIN DAVID J | Director | 50 | 2021–2026 | person page Fuzzy | |
| Mortenson Mark | Officer | Chief Science Officer | 19 | 2021–2026 | |
| Stevens John Henry | Director | 20 | 2021–2023 | ||
| Ugwumba Chidozie | Director; TenPercentOwner; TenPercentOwner,Other | 39 | 2021–2026 | ||
| AK Holding Company, LC | TenPercentOwner | 1 | 2021 | ||
| Mosca Alison | Director; Director,TenPercentOwner | 38 | 2021–2026 | ||
| WILCOX REED N | Director | 18 | 2021–2026 | ||
| Costello Fiona | Director | 4 | 2021 | ||
| General Resonance LLC | TenPercentOwner | 15 | 2021–2025 | ||
| McLaughlin Vallerie | Director | 22 | 2021–2026 | ||
| BROWN MORGAN R | Officer | Chief Financial Officer | 13 | 2022–2026 | |
| Desai Arjun JJ | Director | 14 | 2023–2026 | ||
| Kiernan Matthew | Director | 14 | 2023–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-10-09 | Clene Inc. | Pharmaceuticals | $7,310,060 | $7,310,060 | 13 | 1 |
| 2021-05-26 | Clene Inc. | Pharmaceuticals | $9,250,000 | $9,250,000 | 8 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Clene Inc. | UT | Form D private offerings | CIK (EXACT) |
| SEC filer | Clene Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | David J Matlin | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, UT first:
- ZARS Pharma, Inc. UT
- SANGUI BIOTECH INTERNATIONAL INC UT
- Q Therapeutics, Inc. UT
- SignPath Pharma, Inc. UT
- THAT MARKETING SOLUTION, INC. UT
- REST EZ Inc. UT
- ANESTA CORP /DE/ UT
- NovaCardia Inc CA
- MyoKardia, Inc. CA
- Bioquest Corp CA
In other datasets, the same topic (Health) in UT:
- Nonprofit: 19 HOPE AND HEALING (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health